ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

EMD Group (EMD Serono, Inc. (Rockland)) 

One Technology Place

Rockland  Massachusetts  02370  U.S.A.
Phone: 800-283-8088 Fax: n/a


SEARCH JOBS

Overview
At the EMD Group, around 40,000 people in more than 60 countries develop pharmaceutical and chemical innovations. In 2010 the company generated total revenues of EUR 9.3 billion. It is the world’s oldest pharmaceutical and chemical company with roots dating back to 1668. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

From the start of industrial production in 1827, to initial research on liquid crystals more than 100 years ago, up to our entry into targeted cancer therapy with the launch of Erbitux®, many milestones in our history provide strong evidence of the pioneering spirit of the people at EMD. From innovative drugs to treat multiple sclerosis, cold remedies to new technologies for energy-efficient light sources our pioneering spirit in research and our experience enable us to develop products that improve quality of life.

Since going public in 1995, the company’s operating activities are under the umbrella of Merck KGaA Darmstadt, Germany.

Career Opportunities
Do you want to continue to experiment, analyze and break new ground? Welcome to EMD. When it comes to innovations, you will find us in the front ranks. And the breadth of our ceative research is far-reaching: from medicines, through opportunities in bio-research and bio-production, all the way to liquid crystals for LCDs. Enough latitude, in other words, to make your passion a true calling. Bring us entrepreneurial flair, plenty of team spirit and a total commitment to delivering the best possible results for our customers, and you’ll go far. You’ll enjoy all the interest and exposure of working in multidisciplinary, international teams. Depending on your field of expertise, you may even have the chance to develop across business sectors and functions.

To find out where you could go in an organization that’s part of Merck KGaA, Darmstadt, Germany, a global force in chemicals and pharmaceuticals with operations in more than countries and revenues of €9.3 billion in 2010, please visit come2emd.com.

EMD Group is an Equal Opportunity Employer.

Products:
Pharmaceuticals
EMD Serono is the largest division of the EMD Group and discovers, develops, manufactures and commercializes innovative prescription drugs and therapies for high unmet medical needs. The focus lies in specialist therapeutic areas such as oncology, multiple sclerosis and infertility. Through their targeted effect, these medicines help patients to live a longer and better life. Many consumers around the world trust a wide range of well-known brands that EMD develops, manufactures and markets for the OTC (over-thecounter) pharmaceutical sector.

Chemicals
Our broad range of specialty chemicals are used in technologically sophisticated applications ranging from liquid crystal, to effect pigments and cosmetic ingredients. The EMD Group is the global leader in the liquid crystals market. Liquid crystals are used throughout the world, in LCD TVs, monitors, tablet computers, notebooks, mobile phones, and digital cameras. In addition to the display materials business, the Performance Materials division focuses on materials for energy-saving lighting using LEDs (light-emitting diodes) and OLEDs (organic LEDs). Pigments for the plastics, printing and coatings industries as well as for cosmetic applications are an important part of the Performance Materials portfolio. Moreover, the division is the market leader for pearl-luster effect pigments.

With the EMD Millipore division, the EMD Group is a leading life science company, which offers products, applications and solutions for protein research and cell biology as well as for the manufacture of chemical-based and biopharmaceutical drugs. The portfolio comprises products for life science research such as assays, biomarkers and targeted solutions, as well as bioprocessing, lab water purification and filtration. Additionally, the division supplies specialty chemicals mainly to regulated markets, for example the pharmaceutical, cosmetics and food industries. Analytical and scientific laboratories use the reagents and test kits supplied by the division. The EMD Millipore portfolio comprises more than 40,000 products and processes.
Thank you in advance! I am looking forward to hearing from you.


 Key Statistics


Email:
Ownership: Subsidiary

Web Site: EMD Group (EMD Serono, Inc. (Rockland))
Employees:
Symbol: 
 



Industry
Biotechnology






 Company News
EMD Group (EMD Serono, Inc. (Rockland)) Appoints Drew Young To Senior Vice President, Neurology And Immunology 9/2/2014 1:34:55 PM
EMD Group (EMD Serono, Inc. (Rockland)) Participates In Global Grants Program To Fund Scientific Innovation And Medical Education 7/8/2014 7:46:15 AM
EMD Group (EMD Serono, Inc. (Rockland)) Launches 10th Edition Of The EMD Serono Specialty Digest™ At Annual Meeting Of The Academy Of Managed Care Pharmacy 4/1/2014 9:13:02 AM
EMD Group (EMD Serono, Inc. (Rockland)) Strengthens Leadership With New Appointments 2/13/2014 9:54:42 AM
EMD Group (EMD Serono, Inc. (Rockland)) Release: Commitment of €4 Million Made to the Grant for Fertility Innovation (GFI) for the Years 2013 / 2014 7/9/2013 10:01:40 AM
EMD Group (EMD Serono, Inc. (Rockland)) Establishes Immuno-Oncology Research and Early Development Platform to Advance Innovation in Cancer Therapies 6/26/2013 11:07:28 AM
EMD Group (EMD Serono, Inc. (Rockland)) to Exhibit at 2013 Biotechnology Industry Organization (BIO) International Convention, booth 3340, Apr 22 - 25, 2013, in Chicago IL, US 4/22/2013 8:12:08 AM
EMD Group (EMD Serono, Inc. (Rockland)) and Pfizer Inc. (PFE) Announce FDA Approval of Rebif® Rebidose® 1/3/2013 8:15:05 AM
ACADIA Pharmaceuticals, Inc. (ACAD) to Receive Funding From Fast Forward, LLC and EMD Serono for Multiple Sclerosis Program 12/20/2012 9:36:00 AM
EMD Serono and Fast Forward, LLC Announce Recipients of Funding for Multiple Sclerosis Research 12/20/2012 9:02:10 AM
1234